Patent details

Basic Information

Publication number:

EP2512491

PCT Application Number:

US2010052911

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP108241993

PCT Publication Number:

WO2011047312

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HBV ANTISENSE INHIBITORS

French Title of Invention:

INHIBITEURS ANTISENS DU VHB

German Title of Invention:

HBV-ANTISENSE-HEMMER

SPC Number:

Dates

Filing date:

15/10/2010

Grant date:

11/10/2017

EP Publication Date:

24/10/2012

PCT Publication Date:

21/04/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/10/2017

EP B1 Publication Date:

11/10/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/10/2017

Expiration date:

15/10/2030

Renunciation date:

Revocation date:

13/01/2020

Annulment date:

Owner

From:

11/10/2017

 

 

Name:

Glaxo Group Limited

Address:

980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Inventor

Name:

HAMATAKE, Robert

Address:

United States (US)

Priority

Priority Number:

252380 P

Priority Date:

16/10/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/7115; A61K 31/7125; A61P 1/16; A61P 31/20;

Publication

European Patent Bulletin

1

Issue number:

201741

Publication date:

11/10/2017

Description:

Grant (B1)

2

Issue number:

201833

Publication date:

15/08/2018

Description:

Opposition procedure started

3

Issue number:

202021

Publication date:

20/05/2020

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2018	Outgoing Correspondence	1